25C-NB3OMe
25C-NB3OMe[edit]
25C-NB3OMe is a synthetic psychedelic compound that belongs to the NBOMe class of drugs. It is a derivative of the phenethylamine 2C-C, which is part of the larger 2C family of psychedelic phenethylamines. The NBOMe series is known for its potent agonistic activity at the 5-HT2A receptor, which is primarily responsible for its psychedelic effects.
Chemical Structure[edit]
25C-NB3OMe is chemically known as 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine. The structure of 25C-NB3OMe includes a 2C-C backbone with a methoxybenzyl group attached to the nitrogen atom, which is characteristic of the NBOMe series. This modification significantly increases the compound's affinity for the 5-HT2A receptor compared to its 2C-C parent compound.
Pharmacology[edit]
25C-NB3OMe acts as a potent agonist at the 5-HT2A receptor, which is a subtype of the serotonin receptor family. Activation of this receptor is associated with the psychedelic effects experienced by users. The compound may also interact with other serotonin receptor subtypes, but its primary action is at the 5-HT2A receptor.
Effects[edit]
The effects of 25C-NB3OMe are similar to those of other psychedelics, including altered perception of time and space, visual hallucinations, and changes in thought processes. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.
Legal Status[edit]
The legal status of 25C-NB3OMe varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Users should be aware of the legal implications of possessing or distributing this compound in their region.
